News

Dapagliflozin Lowers Glucose by Raising Glycosuria

Publish date: July 1, 2008
PDF Download

 

Dapagliflozin is now in phase III testing.

Pages

Recommended Reading

Insulin Restriction May Decrease Life Span
MDedge Endocrinology
Macular Edema Tied to Cardiac Risk in Later-Onset Diabetes
MDedge Endocrinology
Extremes in HbA1c Levels Linked to Dementia Risk : Dementia risks increased when HbA1c values reached 12% and higher and when they fell below 5%.
MDedge Endocrinology
Data Watch: Incidence of Diabetes in Elderly Almost Doubled in the last 2 Decades
MDedge Endocrinology
Metabolic Syndrome Linked to Earlier Strokes
MDedge Endocrinology
Fetuin-A Found to Be a Novel Risk Factor for Type 2 Diabetes
MDedge Endocrinology
Poor Childhood Cognition, Type 2 Diabetes Linked
MDedge Endocrinology
Free Diabetes Screening Effort Finds Many at Risk
MDedge Endocrinology
Maternal Hyperglycemia Tied to High Fetal Insulin, Weight
MDedge Endocrinology
Teens With Type 2 Often Misjudge Their Weight
MDedge Endocrinology